Published by
@ShahidNShah
@ShahidNShah
April 23 to April 25, 2024
Hilton Boston Back Bay, 40 Dalton Street, Boston, Massachusetts, 02115, United States
The 5th TCR-based Therapies for Solid Tumors Summit 2024 prioritizes advancing R&D and Clinical Development strategies for TCR therapies, aiming to leverage their potential against solid tumors. These therapies present promising avenues for refining treatment approaches, instilling hope for better outcomes in patients facing challenging conditions. Scheduled from April 23rd to 25th, this summit highlights Adaptimmune's milestone - a Biologics License Application submission - marking significant progress toward regulatory approval for their TCR-based cancer therapy. This achievement signifies a crucial leap forward, opening doors for wider accessibility to this innovative treatment. As the primary gathering spotlighting TCR pipelines, this summit serves as a premier platform for networking with esteemed industry leaders dedicated to expediting TCR-based therapeutic clinical and commercial development.
[Read on tcr-therapies-summit.com](https://tcr-therapies-summit.com/)
Continue reading at tcr-therapies-summit.com
April 23 to April 25, 2024
Steigenberger Airport Hotel Frankfurt, 16 Unterschweinstiege, Frankfurt am Main, Hessen, 60549, Germany
Connecting innovation decision makers to authoritative information, institutions, people and insights.
Medigy accurately delivers healthcare and technology information, news and insight from around the world.
Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.
© 2024 Netspective Media LLC. All Rights Reserved.
Built on Apr 26, 2024 at 6:14am